Cargando…
Regulatory filing strategy for generic mesalazine modified release formulations
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081473/ https://www.ncbi.nlm.nih.gov/pubmed/21572669 http://dx.doi.org/10.4103/0253-7613.77386 |
| _version_ | 1782202218479353856 |
|---|---|
| author | Gupta, Sandeep K. |
| author_facet | Gupta, Sandeep K. |
| author_sort | Gupta, Sandeep K. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3081473 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Medknow Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30814732011-05-13 Regulatory filing strategy for generic mesalazine modified release formulations Gupta, Sandeep K. Indian J Pharmacol Letters to Editor Medknow Publications 2011-04 /pmc/articles/PMC3081473/ /pubmed/21572669 http://dx.doi.org/10.4103/0253-7613.77386 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to Editor Gupta, Sandeep K. Regulatory filing strategy for generic mesalazine modified release formulations |
| title | Regulatory filing strategy for generic mesalazine modified release formulations |
| title_full | Regulatory filing strategy for generic mesalazine modified release formulations |
| title_fullStr | Regulatory filing strategy for generic mesalazine modified release formulations |
| title_full_unstemmed | Regulatory filing strategy for generic mesalazine modified release formulations |
| title_short | Regulatory filing strategy for generic mesalazine modified release formulations |
| title_sort | regulatory filing strategy for generic mesalazine modified release formulations |
| topic | Letters to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081473/ https://www.ncbi.nlm.nih.gov/pubmed/21572669 http://dx.doi.org/10.4103/0253-7613.77386 |
| work_keys_str_mv | AT guptasandeepk regulatoryfilingstrategyforgenericmesalazinemodifiedreleaseformulations |